Filter Results

Locations

Study status

(for at least one location)

Gender

Age

Healthy Volunteer

What is this?
A volunteer subject with no known significant health problems who participates in research to test a new drug, device or intervention. These volunteers are recruited to serve as controls for patient groups. Healthy volunteers receive the same test, procedure, or drug the patient group receives.

Study phase

What is this?
During the early phases (phases 1 and 2), researchers assess safety, side effects, optimal dosages and risks/benefits. In the later phase (phase 3), researchers study whether the treatment works better than the current standard therapy. They also compare the safety of the new treatment with that of current treatments. Phase 3 trials include large numbers of people to make sure that the result is valid. There are also less common very early (phase 0) and later (phase 4) phases. Phase 0 trials are small trials that help researchers decide if a new agent should be tested in a phase 1 trial. Phase 4 trials look at long-term safety and effectiveness, after a new treatment has been approved and is on the market.

Search Results 21-30 of 40 for Clostridium difficile infection

Edit search filters
  1. Microbiota Restoration Therapy for Recurrent Clostridium Difficile-associated Diarrhea

    Scottsdale/Phoenix, AZ

  2. Efficacy of Oral Vancomycin Prophylaxis for Prevention of Recurrent Clostridium Difficile Infection

    Rochester, MN

  3. A Study to Compare Ridinilazole Versus Vancomycin Treatment for Clostridium Difficile Infection (CDI)

    Rochester, MN

  4. A Study To Evaluate the Effectiveness, Safety, And Tolerability of a Clostridium Difficile Vaccine In Adults 50 Years of Age and Older

    Rochester, MN

  5. A Study to Evaluate the Safety and Tolerability of Rebiotix RBX2660 (microbiota suspension) in Subjects with Recurrent Clostridium difficile Infection

    Rochester, MN

  6. An Extension of a Previous Study Evaluating the Use of SER-109 to Prevent Recurrent Clostridium Difficile Infections

    Rochester, MN

  7. Fecal Microbiota Transplantation for C. Difficile Infection in Solid Organ Transplant Recipients

    Rochester, MN

  8. Recurrent Clostridium Difficile vs Post Infectious IBS: A Prospective Study

    Rochester, MN

  9. Fresh Versus Frozen Stool for Fecal Transplant in Children

    Rochester, MN

  10. A Study to Evaluate the Safety, Effectiveness, and Tolerability of Oral Full-Spectrum Microbiota™ (CP101) in Subjects With Recurrent C. Diff

    Rochester, MN

.

Mayo Clinic Footer